#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type II Interstitial lung disease T-cell type acute leukaemia Fungal infection Diffuse large B-cell lymphoma recurrent Deafness neurosensory Hereditary motor and sensory neuropathy Type IIa hyperlipidaemia Brain abscess Rectal cancer Epstein-Barr virus associated lymphoproliferative disorder Red blood cell abnormality Arteriovenous malformation Leber's congenital amaurosis Bronchiectasis More trials…

    Learn about Rare Diseases

    Indolent systemic mastocytosis – Treatment Marfan’s syndrome – Life with Disease Angiosarcoma recurrent – Life with Disease Waldenstrom’s macroglobulinaemia – Life with Disease Friedreich’s ataxia – Life with Disease Alternating hemiplegia of childhood – Trials in Disease Crigler-Najjar syndrome Myelodysplastic syndrome with excess blasts – Life with Disease Medulloblastoma recurrent – Diagnostics Systemic mastocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rimegepant Dorocubicel L-Histidine Hydrochloride Ixazomib Doxorubicin Hydrochloride Lorazepam Linperlisib INSULIN DEGLUDEC Acetylcysteine Amide Damoctocog Alfa Pegol Deucrictibant ZODASIRAN AMO959 Warfarin Sodium Gallium (68Ga) Gozetotide Belinostat Efavirenz Indometacin Ph. Eur. Dermatophagoides Pteronyssinus A3907 More therapies…

    Learn about Your Condition

    Hyponatraemia Dengue fever Metastases to meninges Complex regional pain syndrome Factor VIII deficiency Cerebrovascular accident Renal impairment Cervix carcinoma stage I Muscular dystrophy Carotid arteriosclerosis Cataract Herpes simplex Cervix carcinoma stage III Pemphigoid Relapsing multiple sclerosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study of Pariglasgene Brecaparvovec and Prednisolone for Adults with Glycogen Storage Disease Type Ia

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Glycogen storage disease type I
    Investigated Drugs:
    • Pariglasgene Brecaparvovec
    • Prednisolone
    Denmark Germany Italy The Netherlands Spain

  • Study on Belapectin for Preventing Esophageal Varices in Patients with NASH Cirrhosis

    Not recruiting

    4 1
    Investigated Diseases:
    • Varices oesophageal
    • Hepatic cirrhosis
    Investigated Drugs:
    • Galactoarabino-Rhamnogalacturonate
    Belgium France Germany Poland Spain

  • Study on the Effects of INT-787 for Patients with Severe Alcohol-Associated Hepatitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Hepatitis alcoholic
    Investigated Drugs:
    • Int-787
    France

  • Study on the Effectiveness and Safety of Adding Pioglitazone to Metformin and Empagliflozin for Patients with Type 2 Diabetes with Poor Blood Sugar Control

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Gliclazide
    • Glimepiride
    • Glipizide
    Poland

  • Study on the Effects of Triheptanoin and Medium-chain Triglycerides in Children with Long-chain Fatty Acid Oxidation Disorders

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Fatty acid oxidation disorder
    Investigated Drugs:
    • Doconexent
    • Ovolecithin
    • Triheptanoin
    Czechia Germany Poland Spain

  • Study on the Effects of VS-01 for Adults with Acute-on-Chronic Liver Failure and Ascites

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acute on chronic liver failure
    Investigated Drugs:
    • Citric Acid, Anhydrous Ph. Eur.
    Belgium France Germany Hungary Italy Spain
Previous Page
1 … 48 49 50 51 52 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!